As an important RasGAP, NF1 functions as a tumor suppressor in multiple tumors, and loss of NF1 is common and associated with tumor growth as well as resistance to targeted therapy in CRC [41–43]. This evidence concerns the gene RASA2 and colorectal carcinoma.